Stoke Therapeutics (STOK) PT Raised to $48 at Wedbush, Following Earnings
Tweet Send to a Friend
Wedbush analyst Laura Chico raised the price target on Stoke Therapeutics (NASDAQ: STOK) to $48.00 (from $47.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
